Invasive Cardiology near New Rochelle, NY

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Dr. Nir Uriel, an internationally recognized leader in heart failure, mechanical circulatory support, and heart transplantation, has been named Director of Advanced Heart Failure and Cardiac Transplantation at NewYork-Presbyterian. Dr. Uriel will oversee heart failure programs at NewYork-Presbyterian's campuses in Manhattan, Queens, Brooklyn, and Westchester, with a goal to increase accessibility of care for those with advanced heart failure throughout the New York area. Dr. Uriel was born and raised in Israel, where he attended medical school. After serving for four years as a physician in the Israeli Defense Forces, he then completed his cardiology residency and fellowship. In 2008, he moved to New York to pursue fellowships at NewYork- Presbyterian/Columbia in cardiology, heart failure, transplant, and mechanical circulatory support and remained here as a faculty member until 2014. He then served as the Louis Block Professor of Medicine and Director of Heart Failure, Transplant and Mechanical Circulatory Support at the University of Chicago Medicine, where, in 2018, he and his Chicago team made history performing two tripleorgan transplants within 27 hours. A dedicated researcher with more than 200 peer-reviewed publications, Dr. Uriel has improved treatment protocols for patients with end-stage heart failure and has extended criteria for the use of ventricular assist devices and eligibility for transplant for high-risk patients, including those who are HIV positive. His research continues with a focus on interactions of medical devices, such as VADS, with the human body.

Biography: Dr. Gabriel Sayer is the Associate Director of Advanced Heart Failure, Cardiac Transplantation and Mechanical Circulatory support at NewYork-Presbyterian. In this role, Dr. Sayer provides leadership and oversight for the comprehensive heart failure services provided across NewYork-Presbyterian, including the campuses in Manhattan, Queens, Brooklyn and Westchester. Dr. Sayer attended medical school at the University of Pennsylvania, followed by Internal Medicine residency at Columbia University Irving Medical Center. He completed Cardiology fellowship at Mount Sinai Medical Center and his Advanced Heart Failure fellowship at Massachusetts General Hospital. Prior to joining NewYork-Presbyterian in 2019, Dr. Sayer worked at the University of Chicago for six years, where he was the Associate Director of the Heart Failure, Mechanical Circulatory Support and Cardiac Transplantation programs. In addition to his extensive clinical experience in all aspects of heart failure, Dr. Sayer has published nearly 100 peer-reviewed articles in the field of advanced heart failure. His research interests include the impact of of heart failure treatments on cardiac physiology, with a particular interest in the interaction between patients and mechanical circulatory support devices. https://youtu.be/vT5s8orP6V8

Biography: Dr. Susan Hecht, MD is an Internist who practices in New York, NY. She has been practicing for 44 years. Dr. Susan Hecht, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Dr. Hirad Yarmohammadi, MD is an Internist who practices in New York, NY. He has been practicing for 23 years. Dr. Hirad Yarmohammadi, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Joseph Tenenbaum, MD is the Edgar M. Leifer Professor of Medicine at the College of Physicians and Surgeons at Columbia University. Dr. Tenenbaum is deeply committed to fulfilling the privilege of practicing and teaching medicine. Dr. Tenenbaum' first commitment is to bring the best of modern medicine with the finest art of the classical caring of medicine to heal those who are sick, provide remedy for suffering, and to promote health. His second is to those who come to train; to afford the best experience in realizing one's potential, to present the best examples of medical caregiving. The Columbia University Medical center's Division of Cardiology has flourished in its commitment to education, teaching, and research through a similar focus.

Biography: Mathew S. Maurer, MD - Dr. Maurer is a general internist and geriatric cardiologist with advanced training in heart failure and cardiac transplantation. He is the Arnold and Arlene Goldstein Professor of Cardiology at Columbia University Irving Medical Center, Vagelos College of Physicians & Surgeons, where directs the Clinical Cardiovascular Research Laboratory for the Elderly (CCRLE). Dr. Maurer is a member of the Advanced Cardiac Care Center at NewYork Presbyterian Hospital Columbia Campus. He is the Director of the Cardiac Amyloidosis Program.He has published over 300 articles including peer reviewed manuscripts, reviews and book chapters. He was Chair of the American College of Cardiology's Geriatric Cardiology Member Section, which is the largest organization dedicated to advancing the care of older adults with cardiovascular disease. He was co-chair of the Steering Committee of the ATTR-ACT trial showing tafamidis was a safe and effective therapy for transthyretin amyloid cardiomyopathy. Throughout his career, he has promulgated an approach to older adults with cardiovascular disease that offers the best of both geriatric and cardiovascular medicine in which a comprehensive holistic approach to enhance functional capacity and quality of life is at the forefront of emerging techniques to address cardiovascular physiologic derangement that disproportionately afflict older adults.